↓ Skip to main content

Cochrane Database of Systematic Reviews

Perioperative ketamine for acute postoperative pain

Overview of attention for article published in Cochrane database of systematic reviews, July 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter
2 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
120 Mendeley
Title
Perioperative ketamine for acute postoperative pain
Published in
Cochrane database of systematic reviews, July 2015
DOI 10.1002/14651858.cd004603.pub3
Pubmed ID
Authors

Rae F Bell, Jørgen B Dahl, R Andrew Moore, Eija A Kalso

Abstract

Postoperative pain management is often limited by adverse effects such as nausea and vomiting. Adjuvant treatment with an inexpensive opioid-sparing drug such as ketamine may be of value in giving better analgesia with fewer adverse effects. To evaluate the effectiveness and tolerability of ketamine administered perioperatively in the treatment of acute postoperative pain in adults. Studies were identified from MEDLINE (1966 to 2004), EMBASE (1980 to 2004), the Cochrane Database of Systematic Reviews (2004) and by handsearching reference lists from review articles and trials. The manufacturer of ketamine (Pfizer) provided search results from their in-house database, PARDLARS. Randomised controlled trials (RCTs) of adult patients undergoing surgery, being treated with perioperative ketamine or placebo. Studies where ketamine was administered in addition to a basic analgesic (such as morphine or NSAID) in one study group, and compared with a group receiving the same basic analgesic (but without ketamine) in another group, were also included. Two independent review authors identified fifty five RCTs for potential inclusion. Quality and validity assessment was performed by two independent review authors. In the case of discrepancy, a third review author was consulted. Patient reported pain intensity and pain relief was assessed using visual analogue scales or verbal rating scales and adverse effects data were collated. Thirty-seven trials were included (2240 participants). Eighteen trials were excluded. Twenty-seven of the 37 trials found that perioperative subanaesthetic doses of ketamine reduced rescue analgesic requirements or pain intensity, or both. Quantitative analysis showed that treatment with ketamine reduced 24 hour PCA morphine consumption and postoperative nausea or vomiting (PONV). Adverse effects were mild or absent. Ketamine in subanaesthetic dose (that is a dose which is below that required to produce anaesthesia) is effective in reducing morphine requirements in the first 24 hours after surgery. Ketamine also reduces postoperative nausea and vomiting. Adverse effects are mild or absent.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Mexico 1 <1%
Sweden 1 <1%
Brazil 1 <1%
Unknown 115 96%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 19 16%
Researcher 13 11%
Other 12 10%
Student > Master 11 9%
Student > Doctoral Student 9 8%
Other 33 28%
Unknown 23 19%
Readers by discipline Count As %
Medicine and Dentistry 69 57%
Nursing and Health Professions 7 6%
Agricultural and Biological Sciences 4 3%
Biochemistry, Genetics and Molecular Biology 3 3%
Psychology 3 3%
Other 12 10%
Unknown 22 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2017.
All research outputs
#7,993,771
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,729
of 11,499 outputs
Outputs of similar age
#86,715
of 277,740 outputs
Outputs of similar age from Cochrane database of systematic reviews
#213
of 280 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,740 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 280 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.